Overactivation of mTOR has been involved in cognitive deficits observed in preclinical models of neurodevelopmental disorders, such as tuberous sclerosis, Fragile X syndrome and schizophrenia [20,49,50,51,52,53]. The gene discussed is MTOR; the disease is schizophrenia.